| Insider | Role | Shares | Value | Buys | Sells |
|---|---|---|---|---|---|
| Date | Ticker | Insider | Role | Type | Shares | Price | Value | Chg% | SEC |
|---|---|---|---|---|---|---|---|---|---|
| Insider | Role | Shares | Value | Buys | Sells |
|---|---|---|---|---|---|
| Date | Ticker | Insider | Role | Type | Shares | Price | Value | Chg% | SEC |
|---|---|---|---|---|---|---|---|---|---|
Chief Legal Officer | Director | CLO, SVP of Corp Dev
3 companies
Todd C Girolamo is Chief Legal Officer at PROK and has filed Form 4s across 3 companies. Todd C Girolamo's net worth is not public. Form 4 filings only show shares in the companies where this person is an insider; those holdings are worth an estimated $535K at current prices.
The biggest single holding is PROK (~$351K) as Chief Legal Officer.
Todd C Girolamo has 13 Form 4 filings on record from January 2022 to June 2026, across 3 companies: Chief Legal Officer at ProKidney (PROK), 2022–2026; Director at Longeveron (LGVN), 2022; CLO, SVP of Corp Dev at Lisata Therapeutics (LSTA), 2022.
The 19 reported transactions were 10 option or other derivative awards, 4 tax withholdings, 3 conversions and 2 stock awards.
There are no priced open-market purchases or sales on record, so none of these filings shows a decision to buy or sell shares in the market.
No transactions found
Try adjusting your filters or search criteria